Definium Therapeutics DFTX
NASDAQ DFTX
$38.41 +2.24 (+6.19%)
At close: Sep 28, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Return on Capital Employed [ROCE] (2022 - 2026)

Updated

Definium Therapeutics (DFTX) recorded Return on Capital Employed [ROCE] of -37.93% in Q2 2026, up 18.18 percentage points from -56.11% a year earlier and up 19.01 percentage points from the prior quarter.

Analysis

Definium Therapeutics (DFTX) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends

For FY2025, Definium Therapeutics reported Return on Capital Employed [ROCE] of -54.63%, up 4.92 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a four-year change of +28.91 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -59.55% in FY2024 (+22.06 pp), -81.61% in FY2023 (-37.12 pp), -44.49% in FY2022 (+39.05 pp) and -83.54% in FY2021.
  • The Q2 2026 figure is the highest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in four of the last eight quarters, with an average year-over-year change of +5.36 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 54.93 percentage points in Q4 2024, against a drop of 51.02 percentage points in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -56.94% (Q1 2026), -61.19% (Q4 2025) and -81.47% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 17.83%
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 17.92%
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 6.28%
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 19.32%
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 9.54%
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 16.66%
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -5.97%
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 11.86%
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 20.76%
10 Definium Therapeutics 4.00 Bn 4.00 Bn - -37.93%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.93%
Mar 31, 2026 -56.94%
Dec 31, 2025 -61.19%
Sep 30, 2025 -81.47%
Jun 30, 2025 -56.11%
Mar 31, 2025 -44.09%
Dec 31, 2024 -38.19%
Sep 30, 2024 -35.93%
Jun 30, 2024 -39.34%
Mar 31, 2024 -70.65%
Dec 31, 2023 -93.12%
Sep 30, 2023 -77.32%
Jun 30, 2023 -71.19%
Mar 31, 2023 -49.54%
Dec 31, 2022 -42.10%
Sep 30, 2022 -53.20%
Jun 30, 2022 -52.46%
Mar 31, 2022 -67.45%
API Access

Definium Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DFTX&period=max&api_key=YOUR_API_KEY